The IHE expands Health Economics Team!
The IHE has expanded its health economics team with the addition of three new staff members.
The Institute of Health Economics (IHE) is delighted to introduce three new health economist staff members to its fantastic team: Drs. Jeff Round (Senior Health Economist), Andrew Sutton (Senior Health Economist), and Gareth Hopkin (Research Fellow). Our other IHE health economists include: Drs. Philip Jacobs (Director of Research Collaborations), Thanh Nguyen (Health Economist), Negar Razavilar (Health Economist and Data Analyst), Charles Yan (Health Economist), and Thomas Lo (Health Economist).
Dr. Jeff Round will lead the IHE’s expanded health economics team. Jeff is an Edmonton native returning home after 18 years in the UK, where he completed his training and accrued substantial experience in health technology assessment (HTA) and economic evaluation alongside clinical trials. Jeff is an internationally recognized expert on economic issues around end-of-life care. He is joined by two more imports from the UK – Drs. Gareth Hopkin and Andrew Sutton – who bring expertise in clinical trials and mathematical modelling for technology evaluation, to complement the existing strengths of the health economics team at the IHE. To keep up to date on the team’s activities, follow @IHE_HealthEcon on Twitter.
Dr. Jeff Round, BA (Hons), MA, PhD, specializes in decision analytic modelling and HTA, and his research encompasses both applied and methodological topics in health economics and economic evaluation. Recent applied research projects include evaluations of interventions in palliative and end-of-life care, elder care and dementia, interventions for the treatment of depression, and polypharmacy and medicines management. He has published work across these areas in leading clinical, health economics, and health services and policy journals. A recent paper on the societal costs of providing care at the end of life was recognized as the Research Paper of the Year for 2015 in the journal Palliative Medicine. In 2016, he published an edited book, Care at the end of life: An economic perspective. His primary methodological interest is the assessment of the equitable distribution of health gains within economic evaluations and statistical methods for the estimation of health state utilities.
Dr. Gareth Hopkin has particular interests in the impact and cost-effectiveness of health policies and complex interventions and the health of disadvantaged and underserved populations. He obtained his PhD in Health Services Research at King’s College London, and also holds a BSc (Hons) in Applied Psychology from Cardiff University. Prior to joining the IHE, Gareth was a Fellow in Health Policy at the London School of Economics, where he taught on executive and full-time MSc courses including economic evaluation, research design for health policy, and measuring health system performance), alongside conducting health services research and economic evaluations in several health areas.
Dr. Andrew Sutton has more than 15 years of experience as a health economist working predominantly in the area of economic evaluation. He received his PhD in Biological Sciences at the University of Warwick in the UK. This research focused on the mathematical modelling of infectious diseases. Prior to coming to Canada, Andrew was an Associate Professor in Decision Analytic Modelling at the University of Leeds in the UK. Working mainly in the Test Evaluation Group within the Academic Unit of Health Economics, Andrew undertook a number of economic evaluations of several medical tests at various stages of development. These projects typically involved collaboration between the Diagnostic Evidence Co-operative, Leeds (now the Leeds In-vitro Diagnostics Co-operative) and commercial companies, and sought to encourage the early adoption of new interventions. In the UK, he was a panel member on the National Institute for Health Research (NIHR) General Board with the responsibility for the assessment of applications for the NIHR HTA Programme. Prior to working at the University of Leeds, Andrew was a Lecturer at the University of Birmingham.
The IHE is an independent, not-for-profit organization that performs excellence in health economics research and health technology assessment. Our core objectives include: supporting decision-making in health policy and practice with evidence from research in health economics and health technology assessment; assessing the medical, economic, social, and ethical implications of both established and new health practices, procedures, and technologies; and facilitating discussions and partnerships among government, academia, industry, and healthcare providers to address important issues in health care. Visit us at www.ihe.ca to learn more.
Director of Communications, Institute of Health Economics
Office: (780) 448-4881 | Direct: (780) 401-1768